Game-based assessment tool for young children's neurodevelopment
Evaluation of a Novel Game-based Neurodevelopmental Assessment for Young Children
Brightlobe Limited · NCT05780853
This study is testing a new tablet game to see if it can help tell how well young children, ages 3 to 8, are developing, including those with conditions like ADHD and Autism.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 590 (estimated) |
| Ages | 3 Years to 8 Years |
| Sex | All |
| Sponsor | Brightlobe Limited (industry) |
| Locations | 1 site (London) |
| Trial ID | NCT05780853 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates a novel tablet game-based assessment tool designed for young children aged 3 to 8 years. The primary goals are to determine the tool's ability to accurately differentiate neurodevelopmental status based on children's performance and to assess its validity. The study aims to recruit 590 participants, including both typically developing children and those diagnosed with neurodevelopmental disorders such as ADHD and Autism Spectrum Disorder. Participants will complete the game-based assessment, which evaluates various neuropsychological functions, while parents will provide demographic information.
Who should consider this trial
Good fit: Ideal candidates include children aged 3 to 8 years, both typically developing and those diagnosed with neurodevelopmental disorders.
Not a fit: Children with medical comorbidities or chronic illnesses that affect their ability to complete the assessment may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could provide a more engaging and accurate method for assessing neurodevelopmental disorders in young children.
How similar studies have performed: Other studies have explored game-based assessments, showing promise in engaging children and providing valid results, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 3 to 8 year old 'typically' developing children with no known neurodevelopmental disorder. OR * 3 to 8 year old children with a diagnosed neurodevelopmental disorder, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder. All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment. Exclusion Criteria: * Children with medical comorbidities, a chronic illness or any additional diagnoses that would impact their ability to complete the game-based assessment.
Where this trial is running
London
- Brightlobe Limited — London, United Kingdom (RECRUITING)
Study contacts
- Principal investigator: Jane Iles, PhD DClinPsy — Brightlobe Limited
- Study coordinator: Shivani Lamba
- Email: study@brightlobe.com
- Phone: +447872989457
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neurodevelopmental Disorders, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Dyslexia, Specific Learning Disorder, Child Development, Diagnostic test, Neurodevelopment